Literature DB >> 30516820

Blue Cone Monochromacy Caused by the C203R Missense Mutation or Large Deletion Mutations.

Alexander Sumaroka1, Alexandra V Garafalo1, Artur V Cideciyan1, Jason Charng1, Alejandro J Roman1, Windy Choi1, Supna Saxena1, Valeryia Aksianiuk1, Susanne Kohl2, Bernd Wissinger2, Samuel G Jacobson1.   

Abstract

Purpose: To compare the phenotype of blue cone monochromacy (BCM) caused by large deletion mutations with those having the C203R missense mutation.
Methods: BCM patients with large deletion mutations (n = 21; age range, 5-60 years), and with the C203R missense mutation (n = 13; age range, 5-70 years), were studied with optical coherence tomography, visual acuity, and perimetric sensitivity in a retrospective observational case series. Perceptual estimates of spatial resolution driven by rods, S-cones, and L/M-cones were obtained by the choice of chromatic gratings presented on varied adapting conditions with a modified microperimeter.
Results: Both genotypes had abnormal foveal photoreceptor structure early in life. Patients with the C203R mutation, however, had decades-longer persistence of foveal photoreceptor outer nuclear layer thickness and a slower rate of development of inner segment/outer segment defects than did patients with large deletion mutations. At late ages, both genotypes had comparably severe losses of central structure. At the rod-rich hot spot, there was no difference in structure between cohorts with age. Grating acuities in all BCM patients were driven by S-cones and rods; the foveal structural differences were not reflected in a difference between cohorts in visual sensitivity and spatial resolution. Conclusions: A difference in structural phenotype due to the C203R mutation versus large deletion mutations in BCM was detected as a more prolonged persistence of foveal photoreceptor structure in patients with the missense mutation. This should be taken into account in planning natural history studies, selecting outcomes for clinical trials, and defining the time window for possible therapies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30516820     DOI: 10.1167/iovs.18-25280

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Disease mechanisms of X-linked cone dystrophy caused by missense mutations in the red and green cone opsins.

Authors:  Ping Zhu; Frank Dyka; Xiaojie Ma; Ling Yin; Heather Yu; Wolfgang Baehr; William W Hauswirth; Wen-Tao Deng
Journal:  FASEB J       Date:  2021-10       Impact factor: 5.834

2.  Treatment Potential for Macular Cone Vision in Leber Congenital Amaurosis Due to CEP290 or NPHP5 Mutations: Predictions From Artificial Intelligence.

Authors:  Alexander Sumaroka; Alexandra V Garafalo; Evelyn P Semenov; Rebecca Sheplock; Arun K Krishnan; Alejandro J Roman; Samuel G Jacobson; Artur V Cideciyan
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-06-03       Impact factor: 4.799

3.  Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy.

Authors:  Wen-Tao Deng; Jie Li; Ping Zhu; Beau Freedman; W Clay Smith; Wolfgang Baehr; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-08-01       Impact factor: 4.799

4.  Reading Performance in Blue Cone Monochromacy: Defining an Outcome Measure for a Clinical Trial.

Authors:  Evelyn P Semenov; Rebecca Sheplock; Alejandro J Roman; David B McGuigan; Malgorzata Swider; Artur V Cideciyan; Samuel G Jacobson
Journal:  Transl Vis Sci Technol       Date:  2020-12-08       Impact factor: 3.283

5.  Leber Congenital Amaurosis Due to GUCY2D Mutations: Longitudinal Analysis of Retinal Structure and Visual Function.

Authors:  Samuel G Jacobson; Artur V Cideciyan; Alexander Sumaroka; Alejandro J Roman; Vivian Wu; Malgorzata Swider; Rebecca Sheplock; Arun K Krishnan; Alexandra V Garafalo
Journal:  Int J Mol Sci       Date:  2021-02-18       Impact factor: 5.923

6.  Comparing Retinal Structure in Patients with Achromatopsia and Blue Cone Monochromacy Using OCT.

Authors:  Emily J Patterson; Christopher S Langlo; Michalis Georgiou; Angelos Kalitzeos; Mark E Pennesi; Jay Neitz; Alison J Hardcastle; Maureen Neitz; Michel Michaelides; Joseph Carroll
Journal:  Ophthalmol Sci       Date:  2021-07-28

Review 7.  Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.

Authors:  Alexandra V Garafalo; Artur V Cideciyan; Elise Héon; Rebecca Sheplock; Alexander Pearson; Caberry WeiYang Yu; Alexander Sumaroka; Gustavo D Aguirre; Samuel G Jacobson
Journal:  Prog Retin Eye Res       Date:  2019-12-30       Impact factor: 21.198

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.